The Neo-PLANET phase II trial of neoadjuvant camrelizumab plus concurrent chemoradiotherapy in locally advanced adenocarcinoma of stomach or gastroesophageal junction

The synergistic effect of neoadjuvant immunotherapy and chemoradiotherapy in gastric adenocarcinoma is unclear. This phase II trial (NCT03631615) investigated this neoadjuvant combination in locally advanced adenocarcinoma of stomach or gastroesophageal junction. Thirty-six patients received capecit...

Descripción completa

Detalles Bibliográficos
Autores principales: Tang, Zhaoqing, Wang, Yan, Liu, Dan, Wang, Xuefei, Xu, Chen, Yu, Yiyi, Cui, Yuehong, Tang, Cheng, Li, Qian, Sun, Jing, Zhang, Qian, Ji, Yuan, Ma, Guifen, Li, Haojie, Shen, Zhenbin, Shen, Kuntang, Zheng, Rongrong, Hou, Zhiguo, Liu, Tianshu, Wang, Jiping, Sun, Yihong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9649722/
https://www.ncbi.nlm.nih.gov/pubmed/36357415
http://dx.doi.org/10.1038/s41467-022-34403-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9649722/
https://www.ncbi.nlm.nih.gov/pubmed/36357415
http://dx.doi.org/10.1038/s41467-022-34403-5

Ejemplares similares